Tecan Group AGTCHBF 76 Days Payable is 18.14 as of Dec. 2025, which is 15% above its 10-year median of 15.71. GuruFocus rates TCHBF with a GF Score™ of 76/100 and a GF Value™ of $273.48 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Tecan Group AG ranks worse than 93.84% on this metric.
The historical rank and industry rank for Tecan Group AG's Days Payable or its related term are showing as below:
TCHBF'
s Days Payable Range Over the Past 10 Years
Min: 10.81 Med: 15.71 Max: 21.65
Current: 19.62
During the past 13 years, Tecan Group AG's highest Days Payable was 21.65. The lowest was 10.81. And the median was 15.71.
TCHBF's Days Payable is ranked worse than 93.84% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs TCHBF: 19.62
Tecan Group AG's Days Payable
declined
from Dec. 2024 (20.18) to Dec. 2025 (18.14).
It may suggest that Tecan Group AGaccelerated paying its suppliers.
Tecan Group AG Days Payable Related Terms
Tecan Group AG Days Payable Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tecan Group AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Tecan Group AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (TCHBF) has a Days Payable of 18.14 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tecan Group AG and its competitors. This is 15% above median its historical median of 15.71. Over the past decade, Tecan Group AG's Days Payable has ranged from 10.81 to 21.65. According to the industry distribution chart, Tecan Group AG ranks #746 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 93.8%.
Is Tecan Group AG's Days Payable too high?
Tecan Group AG's current Days Payable of 18.14 is 15% above median its 10-year median of 15.71. Over the past 10 years, this metric has ranged from a low of 10.81 to a high of 21.65. The Medical Devices & Instruments industry median Days Payable is 68.07. Tecan Group AG's value of 18.14 is 73.4% below this industry median. Based on the distribution chart, Tecan Group AG ranks #746 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tecan Group AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #746 out of 795 companies for Days Payable. This places Tecan Group AG in the lower half of its industry. The industry median Days Payable is 68.07. Tecan Group AG's value of 18.14 is 73.4% below this benchmark. Historically, Tecan Group AG's own Days Payable has ranged from 10.81 to 21.65 over the past decade. While the company's 10-year median is 15.71 vs. the industry median of 68.07, Tecan Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tecan Group AG's current Days Payable of 18.14 is 73.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tecan Group AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current Days Payable is 18.14, which is 15% above median its own 10-year median of 15.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (TCHBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $273.48, compared to a current price of $198.00 — trading 27.6% below its estimated fair value. The current Days Payable is 18.14, which is 15% above median its 10-year median of 15.71 and 73.4% below the Medical Devices & Instruments industry median of 68.07. Tecan Group AG's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tecan Group AG (TCHBF), the current Days Payable is 18.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (TCHBF) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued.
The current stock price of $198.00 is trading 27.6% below its estimated GF Value™ of $273.48.
GuruFocus considers Tecan Group AG to be Significantly Undervalued.
Key valuation signals for TCHBF:
Days Payable: 18.14 (15% above median its 10-year median of 15.71)
GF Value™: $273.48 vs. price of $198.00 (27.6% below fair value)
Industry Position: 73.4% below the Medical Devices & Instruments median (#746 of 795)
No single metric tells the full story. See the TCHBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
76GF Score
Get the complete analysis for TCHBF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCHBF has been successfully added to your 
